487 related articles for article (PubMed ID: 11914998)
1. Definitions of cytomegalovirus infection and disease in transplant recipients.
Ljungman P; Griffiths P; Paya C
Clin Infect Dis; 2002 Apr; 34(8):1094-7. PubMed ID: 11914998
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients.
Drew WL
Curr Opin Infect Dis; 2007 Aug; 20(4):408-11. PubMed ID: 17609601
[TBL] [Abstract][Full Text] [Related]
3. Transfusion-transmitted cytomegalovirus infection.
Bowden RA
Hematol Oncol Clin North Am; 1995 Feb; 9(1):155-66. PubMed ID: 7737939
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
Franco A; Serrano R; Gimeno A; de Juan J; Merino E; Jiménez del Cerro L; Olivares J
Nefrologia; 2007; 27(2):202-8. PubMed ID: 17564566
[TBL] [Abstract][Full Text] [Related]
5. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
Singh N; Wannstedt C; Keyes L; Wagener MM; Cacciarelli TV
Liver Transpl; 2005 Jun; 11(6):700-4. PubMed ID: 15915496
[TBL] [Abstract][Full Text] [Related]
6. [Cytomegalovirus infection in renal transplant recipients].
Basić-Jukić N; Racki S; Kes P; Mustapić Z
Acta Med Croatica; 2008; 62 Suppl 1():69-75. PubMed ID: 18578335
[TBL] [Abstract][Full Text] [Related]
7. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
[TBL] [Abstract][Full Text] [Related]
8. Significance of nested PCR and quantitative real time PCR for cytomegalovirus detection in renal transplant recipients.
Kanaan A; Cour I; Alvarez-Lafuente R; Benedicto M; Culebras E; Prats D; Fernández C; Picazo JJ
Int J Antimicrob Agents; 2004 Nov; 24(5):455-62. PubMed ID: 15519477
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
Cummins NW; Deziel PJ; Abraham RS; Razonable RR
Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
[TBL] [Abstract][Full Text] [Related]
10. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
Murray BM; Subramaniam S
Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
[TBL] [Abstract][Full Text] [Related]
12. [Key definitions and concepts in cytomegalovirus: infection versus disease. Replication, viral load, universal prophylaxis. Preemptive therapy].
Montejo M
Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 6():4-5. PubMed ID: 22541914
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system.
Steininger C
Clin Microbiol Infect; 2007 Oct; 13(10):953-63. PubMed ID: 17803749
[TBL] [Abstract][Full Text] [Related]
14. Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.
Ljungman P; Boeckh M; Hirsch HH; Josephson F; Lundgren J; Nichols G; Pikis A; Razonable RR; Miller V; Griffiths PD;
Clin Infect Dis; 2017 Jan; 64(1):87-91. PubMed ID: 27682069
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus. A common virus causing serious disease.
Rawlinson W; Scott G
Aust Fam Physician; 2003 Oct; 32(10):789-93. PubMed ID: 14596071
[TBL] [Abstract][Full Text] [Related]
16. [Cytomegalovirus infection in lung transplantation; current status, detection, prophylactic treatment].
Aoe M; Tao H; Yamane M; Toyooka S; Sano Y; Okazaki M; Date H
Kyobu Geka; 2007 Oct; 60(11):988-92. PubMed ID: 17926902
[TBL] [Abstract][Full Text] [Related]
17. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
Naumnik B; Małyszko J; Chyczewski L; Kovalchuk O; Małyszko J; Myśliwiec M
Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976
[TBL] [Abstract][Full Text] [Related]
18. Onset and duration of cytomegalovirus immediate early 1 mRNA expression in the blood of renal transplant recipients.
Goossens VJ; Christiaans MH; Blok MJ; Terporten PH; Sillekens P; Lukacsi A; Van Hooff JP; Bruggeman CA
J Med Virol; 2004 Jan; 72(1):94-101. PubMed ID: 14635016
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation.
Ghisetti V; Barbui A; Franchello A; Varetto S; Pittaluga F; Bobbio M; Salizzoni M; Marchiaro G
J Med Virol; 2004 Jun; 73(2):223-9. PubMed ID: 15122796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
